Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2015 Packed With Catalysts For Neurocrine Bio
Yahoo/Zacks.com
Tuesday, November 4, 2014 - 1:25pm
tags:
Neurocrine Biosciences
Novo Nordisk builds blockbuster case with promising PhIII obesity data
Fierce Biotech
Tuesday, November 4, 2014 - 10:39am
tags:
Novo Nordisk, obesity, liraglutide
AstraZeneca Is Attractive Even Without Pfizer Bid
Seeking Alpha
Tuesday, November 4, 2014 - 10:35am
tags:
AstraZeneca, M&A, Pfizer
Amgen ovarian cancer drug fails to improve overall survival
Reuters
Tuesday, November 4, 2014 - 10:30am
tags:
Amgen, ovarian cancer, trebananib
FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need
TheStreet.com
Tuesday, November 4, 2014 - 10:26am
tags:
Rockwell Medical, devices, dialysis, Triferic, FDA
Impax Labs misses 3Q profit forecasts
Yahoo/AP
Tuesday, November 4, 2014 - 9:54am
tags:
earnings, Impax Labs
Small Device Maker Fights FDA on ‘Grandfather’ Claim
Medical Device and Diagnostics Industry
Tuesday, November 4, 2014 - 9:33am
tags:
devices, FDA, Pharmaceutical Innovations
FDA Clears ISCO's Stem Cell Line for Clinical Uses
Yahoo
Tuesday, November 4, 2014 - 9:26am
tags:
stem cells, FDA, ISCO
Meet The Biopharma Stock That Lost 34% Last Week
Yahoo/Benzinga
Tuesday, November 4, 2014 - 9:13am
tags:
Aegerion Pharmaceuticals
Tekmira Shares Surge Amid Promise of Ebola Treatment
Bloomberg
Tuesday, November 4, 2014 - 9:12am
tags:
Tekmira, ebola virus, TKM-EBOLA
AstraZeneca strengthens cancer business with new deals
Yahoo/Reuters
Tuesday, November 4, 2014 - 9:11am
tags:
AstraZeneca, cancer, Definiens, M&A
Stryker to pay at least $1.43 billion to settle thousands of lawsuits over hip implants
Yahoo/AP
Tuesday, November 4, 2014 - 9:06am
tags:
Stryker, hip implants, devices
Orexigen's Contrave Has Modest Start
Seeking Alpha
Monday, November 3, 2014 - 6:42pm
tags:
Orexigen, Contrave, obesity
Allergan Confirms White Knight Approach By Actavis, But Coyly
WSJ Online
Monday, November 3, 2014 - 3:46pm
tags:
Allergan, M&A, Valeant Pharmaceuticals, Actavis
Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized
WSJ Pharmalot
Monday, November 3, 2014 - 3:40pm
tags:
Bristol-Myers Squibb, hepatitis C, Daklinza, daclatasvir
Allergan M&A Executive Leaves Amid Hostile Bid
WSJ Online
Monday, November 3, 2014 - 2:22pm
tags:
Allergan, M&A, Valeant Pharmaceuticals
Allergan says has been approached by another party about a deal
Yahoo/Reuters
Monday, November 3, 2014 - 11:59am
tags:
Allergan, Valeant Pharmaceuticals, M&A, Actavis
Hemispherx’s Alferon And Ampligen Effective Against Ebola Virus
Bidness Etc.
Monday, November 3, 2014 - 11:53am
tags:
Hemispherx Biopharma, ebola virus, Alferon, Ampligen
Amgen and Sandoz Square Off Over a Biosimilar Application
WSJ Pharmalot
Monday, November 3, 2014 - 11:45am
tags:
Amgen, Sandoz, biosimilars, Neupogen
Wockhardt says U.S. export ban unlikely to be lifted until next year
Yahoo/Reuters
Monday, November 3, 2014 - 11:44am
tags:
Wockhardt, drug manufacturing, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.